{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:42Z","timestamp":1786480242333,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Population-based retrospective cohort study to evaluate clinical correlates of gout and its impact on patients undergoing chronic dialysis.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>13.5% of US dialysis-dependent patients had gout and were older and male, with a higher prevalence of hypertension and cardiovascular disease.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Gout diagnosis was associated with a higher incidence of cardiovascular conditions, levels of anemia, hospitalization, and mortality.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An association between gout and nondialysis chronic renal disease has long been recognized, yet limited research exists regarding prevalence, treatment, anemia management, and outcomes in patients with ESKD undergoing dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from United States Renal Data System, we conducted a population-based retrospective cohort study in adult patients covered by Medicare and on dialysis in 2017. Multivariate logistic regression models were used to estimate potential factors and odds of gout diagnosis. Antigout medications and impact on anemia management were assessed and compared between gout and nongout dialysis patients using descriptive and regression analyses. Associations for all-cause mortality and cardiovascular-related hospitalizations during 1 year of study follow-up were compared between gout and nongout patients using multivariate Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 231,841 ESKD Medicare patients in 2017 undergoing continuous dialysis, 31,300 (13.5%) had one or more gout diagnostic code(s). Increased odds of having a gout diagnosis were independently associated with older age, male sex, Asian race, obesity, hypertension, and cardiovascular disease. Gout diagnosis was associated with higher prevalence for anemia as indicated by increased erythropoietin-stimulating agent requirements (odds ratio=1.18 for high versus low erythropoietin-stimulating agent dose, 95% confidence interval [95% CI], 1.14 to 1.22) and likelihood of blood transfusions (odds ratio=1.34, 95% CI, 1.30 to 1.38). During the 1-year study follow-up, mortality among gout versus nongout patients was higher by 3% (95% CI, 0 to 6) and a composite association of mortality and cardiovascular disease hospitalization was higher by 6% (95% CI, 3 to 9) after adjusting for comorbid conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A gout diagnosis was found in 13.5% of US dialysis-dependent patients and was associated with a higher burden of comorbid cardiovascular conditions as well as an elevated incidence of hospitalization and mortality. These observations improve our current understanding of gout among the dialysis population and highlight the importance of new and better treatments to improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0004132022","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:50:11Z","timestamp":1670349011000},"page":"177-187","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Gout among Patients with Dialysis: Prevalence, Associated Factors, Treatment Patterns, and Outcomes\u2014Population-Based Retrospective Cohort Study"],"prefix":"10.34067","volume":"4","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[{"name":"Medical Technology and Practice Patterns Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar","family":"Kshirsagar","sequence":"additional","affiliation":[{"name":"Medical Technology and Practice Patterns Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad A.","family":"Marder","sequence":"additional","affiliation":[{"name":"Horizon Therapeutics plc, Deerfield, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy R.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Horizon Therapeutics plc, Deerfield, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"LaMoreaux","sequence":"additional","affiliation":[{"name":"Horizon Therapeutics plc, Deerfield, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Bleyer","sequence":"additional","affiliation":[{"name":"Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"issue":"4 suppl 1","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B3-20250823","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"B4-20250823","first-page":"498","article-title":"Gout in ambulatory care settings in the United States","volume":"35","author":"Krishnan","year":"2008","journal-title":"J Rheumatol."},{"issue":"3","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of gout and hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/ar4026","article-title":"Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study","volume":"14","author":"McAdams-DeMarco","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/SMJ.0000000000000082","article-title":"Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street","volume":"107","author":"Karis","year":"2014","journal-title":"South Med J."},{"issue":"1","key":"B8-20250823","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/0886022X.2020.1835674","article-title":"Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients","volume":"42","author":"Rohn","year":"2020","journal-title":"Ren Fail."},{"issue":"3","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(12)80995-4","article-title":"Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases","volume":"23","author":"Ifudu","year":"1994","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2169\/internalmedicine.44.706","article-title":"Frequency of gouty arthritis in patients with end-stage renal disease in Japan","volume":"44","author":"Ohno","year":"2005","journal-title":"Intern Med."},{"issue":"11","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1681\/ASN.2007111256","article-title":"Association of incident gout and mortality in dialysis patients","volume":"19","author":"Cohen","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2018.11.003","article-title":"The US Renal Data System at 30 years: a historical perspective","volume":"73","author":"Port","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B13-20250823","first-page":"55","article-title":"Medicare's end stage renal disease program","volume":"22","author":"Eggers","year":"2000","journal-title":"Health Care Financ Rev."},{"issue":"4","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.semarthrit.2016.08.006","article-title":"The rising prevalence and incidence of gout in British Columbia, Canada: population-based trends from 2000 to 2012","volume":"46","author":"Rai","year":"2017","journal-title":"Semin Arthritis Rheum."},{"issue":"11","key":"B15-20250823","doi-asserted-by":"crossref","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009-10","volume":"7","author":"Krishnan","year":"2012","journal-title":"PLoS One."},{"issue":"10","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","article-title":"Long-term cardiovascular mortality among middle-aged men with gout","volume":"168","author":"Krishnan","year":"2008","journal-title":"Arch Intern Med."},{"issue":"16","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"e009328","DOI":"10.1161\/JAHA.118.009328","article-title":"Association of gout with long-term cardiovascular outcomes among patients with obstructive coronary artery disease","volume":"7","author":"Pagidipati","year":"2018","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"B18-20250823","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ijms21030725","article-title":"The influence of inflammation on anemia in CKD patients","volume":"21","author":"Gluba-Brz\u00f3zka","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"11","key":"B19-20250823","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Richette","year":"2014","journal-title":"Nat Rev Rheumatol."},{"issue":"1","key":"B20-20250823","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-020-02260-6","article-title":"Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study","volume":"22","author":"Toprover","year":"2020","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"B21-20250823","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.semarthrit.2020.04.010","article-title":"Therapeutic approaches in the treatment of gout","volume":"50","author":"Pillinger","year":"2020","journal-title":"Semin Arthritis Rheum."},{"issue":"22","key":"B22-20250823","doi-asserted-by":"crossref","first-page":"12394","DOI":"10.3390\/ijms222212394","article-title":"Uric acid in inflammation and the pathogenesis of atherosclerosis","volume":"1722","author":"Kimura","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B23-20250823","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000496636","article-title":"The hepcidin-anemia axis: pathogenesis of anemia in chronic kidney disease","volume":"198","author":"Nakanishi","year":"2019","journal-title":"Contrib Nephrol."},{"issue":"10","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and metabolic syndrome: a tangled web","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr Rheumatol Rep."},{"issue":"1","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clindermatol.2017.09.004","article-title":"Pathophysiology of the metabolic syndrome","volume":"36","author":"McCracken","year":"2018","journal-title":"Clin Dermatol."},{"issue":"6","key":"B26-20250823","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"2","key":"B27-20250823","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archinte.160.2.197","article-title":"Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project","volume":"160","author":"Goff","year":"2000","journal-title":"Arch Intern Med."},{"issue":"1","key":"B28-20250823","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J."},{"issue":"10","key":"B29-20250823","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/01.STR.0000032240.28636.BD","article-title":"Validating administrative data in stroke research","volume":"33","author":"Tirschwell","year":"2002","journal-title":"Stroke."},{"issue":"5","key":"B30-20250823","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care."},{"issue":"13","key":"B31-20250823","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2022.1820","article-title":"Collider bias","volume":"327","author":"Holmberg","year":"2022","journal-title":"JAMA."},{"issue":"4","key":"B32-20250823","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiology."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0004132022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:55Z","timestamp":1786478395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0004132022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0004132022","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"assertion":[{"value":"2022-06-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}